Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2965156rdf:typepubmed:Citationlld:pubmed
pubmed-article:2965156lifeskim:mentionsumls-concept:C1261473lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0041385lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0085535lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0049517lld:lifeskim
pubmed-article:2965156lifeskim:mentionsumls-concept:C0673362lld:lifeskim
pubmed-article:2965156pubmed:issue2lld:pubmed
pubmed-article:2965156pubmed:dateCreated1988-5-6lld:pubmed
pubmed-article:2965156pubmed:abstractTextSynthesis and expression of cell surface carbohydrates appear to be involved in recognition events associated with tumor invasion and metastasis. Thus, the potential of murine sarcoma L-1 cells to form experimental lung metastases after i.v. injection was assessed after inhibiting tumor cell protein glycosylation with tunicamycin, swainsonine, bromoconduritol, or 1-desoxynojirimycin. Incubation of sarcoma L-1 cells with 0.5 microgram (or above) of these substances/ml medium for 20-24 h significantly inhibited lung colonization. Cytotoxic side effects or additional organ manifestations could not be found. Gas liquid chromatographic examinations of carbohydrates from treated L-1 cells indicated that sugar synthesis was evidently inhibited. These results suggest that specific glycan structures on tumor cells are required for expression of the metastatic phenotype.lld:pubmed
pubmed-article:2965156pubmed:languageenglld:pubmed
pubmed-article:2965156pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:citationSubsetIMlld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2965156pubmed:statusMEDLINElld:pubmed
pubmed-article:2965156pubmed:issn0171-5216lld:pubmed
pubmed-article:2965156pubmed:authorpubmed-author:UhlenbruckGGlld:pubmed
pubmed-article:2965156pubmed:authorpubmed-author:PulvererGGlld:pubmed
pubmed-article:2965156pubmed:authorpubmed-author:KoH LHLlld:pubmed
pubmed-article:2965156pubmed:authorpubmed-author:OhshimaYYlld:pubmed
pubmed-article:2965156pubmed:authorpubmed-author:YassinAAlld:pubmed
pubmed-article:2965156pubmed:authorpubmed-author:RoszkowskiKKlld:pubmed
pubmed-article:2965156pubmed:authorpubmed-author:BeuthJJlld:pubmed
pubmed-article:2965156pubmed:issnTypePrintlld:pubmed
pubmed-article:2965156pubmed:volume114lld:pubmed
pubmed-article:2965156pubmed:ownerNLMlld:pubmed
pubmed-article:2965156pubmed:authorsCompleteYlld:pubmed
pubmed-article:2965156pubmed:pagination217-20lld:pubmed
pubmed-article:2965156pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:meshHeadingpubmed-meshheading:2965156-...lld:pubmed
pubmed-article:2965156pubmed:year1988lld:pubmed
pubmed-article:2965156pubmed:articleTitleGlycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice.lld:pubmed
pubmed-article:2965156pubmed:affiliationInstitute of Hygiene, University of Cologne, Federal Republic of Germany.lld:pubmed
pubmed-article:2965156pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2965156pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2965156lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2965156lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2965156lld:pubmed